New Treatments for Vaginal Health. Sarah Azad, MD El Camino Women s Medical Group

Similar documents
Menopause Symptoms and Management: After Breast Cancer

There are a variety of ways to address VVA. Keep yourself healthy, avoid irritants to the vulva and vagina, and use moisturizers and lubricants.

Innovations in the Management of Dyspareunia

Women s Health: Managing Menopause. Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School

Year: Issue 1 Obs/Gyne The silent epidemic: Postmenopausal vaginal atrophy

Management of Menopausal Symptoms

Sexual dysfunction in women with cancer: Navigating intimacy and intercourse between women and their partners

Presentation 10 Feb 2, 2019

Sexuality After the Diagnosis of Ovarian Cancer

Renewing Intimacy & Sexuality after Gynecologic Cancer

Energy Based Therapies in Gynecology and Vaginal Health: Update on CO 2

Laser CO2: una terapia ambulatoriale innovativa nel trattamento delle disfunzioni sessuali femminili

A Non-Hormonal Approach to Preventing Vulvovaginal Atrophy from Aromatase Inhibitors (AIs)

Body image and sexuality issues after surgery or cancer

Sexuality and Sexual Dysfunction in Women

Summary of the risk management plan (RMP) for Senshio (ospemifene)

The Leeds Teaching Hospitals NHS Trust Feminine care after pelvic radiotherapy

Southern California Center for Sexual Health and Survivorship Medicine Inc, Newport Beach, CA 3

OB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc.

Amy Siston, Ph.D. July 9, 2017

Treating GSM without Estrogens. Lubrication and Vaginal Dilators

The Study of Tamoxifen and Raloxifene (STAR): Questions and Answers. Key Points

WHI Estrogen--Progestin vs. Placebo (Women with intact uterus)

WHI Form 55 Estrogen-Alone Survey Ver. 2

Learning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories

Management of Menopausal Symptoms in Patients with Breast Cancer. Mike Dixon Edinburgh Breast Unit

MENOPAUSE. I have no disclosures 10/11/18 OBJECTIVES WHAT S NEW? WHAT S SAFE?

Women's Cancer & Sexuality Diljeet K. Singh, MD, DrPH CANCER SURVIVOR DAY

Managing menopause in Primary Care and recent advances in HRT

Process of Aging. Manifestation of Estrogen and/or Androgen Loss: Symptoms Over Time. Estrogen Decrease and Its Impact on Sexual Functioning

2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK

NAMS in the News 2016

Leslie R. Schover, PhD Department of Behavioral Science

Prior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD

Managing menopause in Primary Care and recent advances in HRT

Female Sexual Health: Practical Pointers During and After Cancer

Menopausal Management: What Has Changed?

Winning the War on Women s Cancer Sexual Health & Survivorship

By J. Jayasutha Lecturer Department of Pharmacy Practice SRM College of Pharmacy SRM University

Sexuality. Renewing Intimacy and. After Gynecologic Cancer. Gynecologic Cancer Foundation. Women s Cancer Network Web Site:

DR REBECCA LEVY-GANTT HOT TOPICS IN OBGYN 2018

FemTouch Treatment for Improving Vulvovaginal Health

Dyspareunia: Best Practices in Counseling, Diagnosis, and Therapy

Birth Control Options Chart

The following section of this program contains some material that may be considered sensitive or personal.

Vaginitis. Antibiotics Changes in hormone levels due to pregnancy, breastfeeding, or menopause Douching Spermicides Sexual intercourse Infection

Understanding Women's Sexuality after Bladder Cancer webinar. Part I: The Physical Impact

Haelle T. Changing the conversation about hormone therapy in menopause. Medscape, 2017; accessed

MENOPAUSAL HORMONE THERAPY 2016

2/28/2018. This presentation contains images of a graphic nature and are presented for medical education only. New Terminology Old Problem!

BIRTH CONTROL METHOD COMPARISON CHART

Vulvo-vaginal atrophy (VVA) materials for use with and Electronic Health Record

OBSTETRICS & GYNECOLOGY

Sexuality in Later Life

Use of vaginal dilators when receiving radiotherapy to the pelvis

VVA : new therapeutic options? BMS october 2017 A Pintiaux

The Good, The Bad, and The Ugly of Hormonal Therapy, Trastuzumab and Docetaxel

Women s Intimacy, Sexuality and Relationship Issues After Cancer

Vaginal atrophy is a common condition

Regaining sexual activity after major bowel surgery. Advice for women

100% Highly effective No cost No side effects

Long Term Toxicity of Endocrine Therapy for premenopausal women with ER positive breast cancer

Sex Cells The effect of hormones on peri- and post- menopausal female sexuality Dr. Cathy Caron November 24, 2011

OBSTETRICS & GYNECOLOGY

What is the menopause?

How cancer treatments may affect your vagina How a vaginal dilator may help you How to use vaginal dilators Where to buy vaginal dilators

Management of Vaginal Prolapse

Treating cancer of the endometrium. Information for patients Gynaecology

A Practitioner s Toolkit for the Management of the Menopause

Sex and Sexuality During and After Cancer Treatment: Yes, there are things that help!

Palm Beach Obstetrics & Gynecology, PA

Sexual problems- some basic information

GYNAELASE SPECIALIST CLINICS OF AUSTRALIA. for successful applicants. No need to wait for treatment.

9/19/16. Disclosures. Sexuality and Intimacy. No conflicts to disclose. As recognized by WHO: Sexual health is a fundamental human right

Interventions to Address Sexual Problems in People with Cancer

Smear Takers Talk- Problems you may encounter during smear taking and things to consider.

Contraception Effective Methods of Birth Control

Female Sexual Dysfunction: Common Problem But Uncommonly Discussed

Ohio Northern University HealthWise. Authors: Alexis Dolin, Andrew Duska, Hannah Lamb, Eric Miller, Pharm D Candidates 2018 May 2018

New Terminology Old Problem!

Menopause and Post Gynecological Reproductive Care

Professor Christian Phillips BSc Hons BM DM FRCOG Consultant Gynaecologist and Urogynaecologist

WHAT ARE CONTRACEPTIVES?

Innovative Nuclear Receptor Modulation Medicine

Radiation Oncology Patient information. Radiation Therapy for gynaecological cancers

Taking a medicine to reduce the chance of developing breast cancer

MENOPAUSE - WHAT TO EXPECT CONCLUSION WEB LINKS

Menopause & HRT. Rosie & Alex. Image:

Female Sexual Hormones Indications and Therapy

Surgery to Reduce the Risk of Ovarian Cancer. Information for Women at Increased Risk

By Milena Mincigrucci*, Costante Donati Sarti**, Angelamaria Becorpi***, Massimo Milani, and Gianluca Botta

Emerging Challenges in Primary Care: Managing Menopause: Update on The Role and Rationale of Hormonal Therapy. Faculty.

First Cancer, Then Sex. Sexuality and Intimacy During and After Cancer

Who s The Daddy? What You Should Know About OTC Contraception

Participant Objectives

Radiation Oncology Patient information. Brachytherapy for intrauterine and vaginal vault cancers

Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved.

Management of Urogenital Prolapse of Women in Primary Care. Lizzie McManus MBE RGN RMN Practice nurse Womens health practitioner

High Dose Rate (HDR) brachytherapy for cancer of the cervix

Why do I need any hormone replacement? What is Menopause? What symptoms are treated by estrogen Injections?

Transcription:

New Treatments for Vaginal Health There s Hope Sarah Azad, MD El Camino Women s Medical Group

The Genitrourinary Syndrome of Menopause (GSM) Problems with genital health secondary to the changes that occur in a woman's body after breast cancer treatment or during menopause. -Millions affected, few seek help

It refers to changes in gynecologic health and it happens to a majority of women. As many as 50% of 64 million women are suffering from changes in their gynecologic health 1,2,3

Scope - It's estimated by 2025, 1.1 billion women over 50 will be affected Symptoms - Physical (Women's Health Initiative Study) - Vaginal dryness - Irritation, itching, discharge - Pain with intercourse - Frequent urination, loss/leaking of urine - Pelvic floor relaxation - unlike hot flashes and other menopausal symptoms, GSM does not spontaneously remit - GSM symptoms get worse with time

Scope - It's estimated by 2025, 1.1 billion women over 50 will be affected Symptoms - Social (From the Vaginal Health: Insights, Views, and Attitudes survey) - Negative impact on one's life/ decreased libido (80%) - Negative consequences in their sexual life (75%) - Negative effects on their marriage or relationship (33%) - Negative impact on self esteem(26%)

What Happens: Loss of Estrogen Vagina loses elasticity, shortens, narrows & easily traumatized Loss of rugae, cervix becomes flush with vaginal walls Petechiae may be present ph greater than 5.0, parabasal cells dominate Repopulation with diverse vaginal flora leads to frequent UTIs Worse with chemo (Tamoxifen, aromatase inhibitors, etc)

Well-estrogenized Premenopausal State Low-estrogen Postmenopausal State Courtesy of the Graphic Courtesy Dr. Diane Todd Pace NP from the North American Menopause Society

Gandhi J, Chen A, Dagur G, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016;215(6):704-711.

What s A Girl To Do? 5 Major Treatment Categories - Regular vaginal stimulation - Over the counter products - Prescription hormone treatments - Ospemifene - Vaginal laser treatments

Regular vaginal stimulation Regular (2-3 times/week) sexual arousal promotes bloodflow Regular sexual activity Regular masturbation or use of a vibrator Regular vaginal dilation helps prevent narrowing of the canal Regular vaginal penetrative sexual activity Use of a dilator

Vaginal Dilators Easy to purchase privately online Allow for gradual dilation of an already narrowed vagina Once penetration of desired size is comfortable, Continue 2-3 times a week for 5-10 minutes Traditional dilators: increase by 2-7 mm each size can use with any lubricant Newer Milli dilator: inflates by 1 mm increments cannot use with silicone lubricants

Over The Counter Lubricants - Regular moisturizer best for persistent dryness - Replens, RepHresh, used 2-3/week - Lubricants also needed with intercourse - Water based, oil based, silicone based - Benefits: cheap, accessible, no systemic affects - Downside: regular use, can be messy

Vaginal Estrogens - Now come in many different forms; suppositories, creams, rings, etc. - Must use 2-3 times weekly (except rings) or they stop working - Benefits: have been in use for many years, safe for most women - Downside: can be messy, can be expensive, requires regular use - For women with a history of cancer, may not be candidates

DHEA Vaginal Ovules - Intrarosa (prasterone) recently FDA approved for the treatment of moderate to severe pain with intercourse - Vaginal pill, once a day - Benefits: vaginal use, safe for most women - Benefits seen in 2 weeks, does not affect uterus - Affordable with coupon card for commercially insured patients - Downside: can be messy, can be expensive, must use daily - Not studied in women with breast cancer - Can be expensive, not yet covered by Medicare

Ospemifene - Selective Estrogen Receptor Modulator (SERM) approved for pain with sex - Prescription medication with estrogen agonist and antagonist actions in the body - Daily oral tablet - Pro-estrogen effect in the vagina and bone - Minimally pro-estrogenic in the uterus - Anti-estrogen effect in the breast - See full effect after 12 weeks of use

Ospemifene - Benefits: - Study group followed for a year, found to have good efficacy and safety results - Daily oral tablet - Promising data for breast cancer survivors - Downside: - Side effects: hot flashes, vaginal bleeding and endometrial hyperplasia - Not yet approved in breast cancer patients - Cannot be taken concurrently with Tamoxifen - Slight increased risk of venous thrombosis - Can be expensive

Fractional CO2 Laser Treatments - Nonsurgical, outpatient procedure - Clinically proven to bring long-lasting relief - Overwhelming positive and immediate results - Less than 1% of reported side effects - Thousands of women treated since 2008 - Approved in the US late 2014

Fractional CO2 Laser Treatments - Procedure: - In office - Three treatments, each 6 weeks apart - No anesthesia needed for internal treatment - Topical lidocaine needed for external treatment - Visit time between 10-30 minutes - Maintenance: - One treatment a year (on average)

Fractional CO2 Laser Treatments - Benefits: - Minimal side effects - No downtime - Treatments have lasting effects - No further need for vaginal estrogens - Downsides: - Cost, not covered

Clinically Proven to bring long-lasting relief. A multicenter trial 1 of menopausal women and breast cancer survivors who were treated with MonaLisa Touch observed: Overwhelmingly positive and immediate results Highly statistically significant improvement in symptoms (including dryness, pain, itching, painful urination and painful intercourse) after first treatment No reported side effects or adverse reactions Escalation of progress with each subsequent treatment https://youtu.be/yp5wpoiieuu